Raymond James Downgrades Neogenomics (NEO) to Market Perform

February 25, 2021 4:32 AM EST
Get Alerts NEO Hot Sheet
Price: $49.51 +1.23%

Rating Summary:
    16 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 17 | New: 52
Trade Now! 
Join SI Premium – FREE

Raymond James analyst Andrew Cooper downgraded Neogenomics (NASDAQ: NEO) from Outperform to Market Perform.


For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.


Shares of Neogenomics closed at $54.34 yesterday.


You May Also Be Interested In





Related Categories

Downgrades